
Sales fell 10.5% to CHF 442.1m in FY2025 while EBIT plunged 61% to CHF 6.0m (1.4% margin vs medium-term target >8%) and net profit declined 54.9% to CHF 5.3m. Order intake was stable at CHF 472.8m (-0.7%) with backlog up 3.2% to CHF 336.4m; aerospace orders jumped 40.1% to CHF 126.5m while luxury orders collapsed 45% to CHF 28.4m. Free cash flow swung to CHF 35.4m (from -CHF 7.0m) and the company ended with net cash of CHF 29.6m; the board proposes a CHF 1.00/share dividend—key monitorables are margin recovery, continued aerospace momentum, and realization of merger synergies.
StarragTornos sits at an inflection where a structurally higher-share aerospace/defense mix can lift sustainable margins even if underlying industrial end markets stay soft. The margin lever is not just topline mix but utilization — converting backlog into higher-capacity, higher-margin aerospace runs will compress unit overhead and amplify recent cost-savings, but this requires ~6–18 months of steady conversion and disciplined pricing to be visible in operating profit. An overlooked lever is installed-base service: recurring aftermarket contracts can stabilize free-cash-flow volatility and functionally derisk capital intensity, creating a convex payoff if management converts a meaningful portion of service sales into multi-year, indexed contracts. Second-order winners include precision sub-suppliers (metrology, specialty cutters, high-torque spindles) and automation integrators that can scale with aerospace programs; conversely, OEMs tied to luxury watchmaking face a deeper cyclical reset in capex that will likely force smaller suppliers into consolidation. There is also a tactical supply-chain read-through: higher defense/aero content increases demand for long lead-time, tightly specified alloys and inspection capacity—this will push order visibility further out and create near-term bottlenecks that incumbents with validated programs can monetize via price and lead-time premiums. Finally, the balance-sheet swing toward net-cash provides optionality for bolt-on buys targeted at software/automation features that accelerate cross-selling between the Starrag and Tornos platforms, a cheaper path to margin than pure organic volume recovery. Key risks are execution and timing: failure to sustain aerospace wins or slower-than-expected backlog conversion will re-expose fixed-cost leverage and could force pricing to drive utilization, compressing margins for 12–24 months. Macro tail-risks (a short, sharp global growth slowdown or new trade barriers) would hurt transportation and MedTech more than defense, so monitor order-book composition and announced long-term service contracts as forward indicators. A potential reversal catalyst is visible traction in multi-year defense contracts or signed long-term maintenance agreements; absent these, the market will reprice the stock toward a lower multiple reflecting cyclical end-market exposure.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment